This article from OneBuild takes a hard look at why industrialized construction, once touted as the future of affordable, efficient homebuilding, hasn’t delivered at scale despite billions in investment. The article surveys a string of high-profile setbacks in the sector and argues that the problem is not a lack of ambition or technology, but structural misalignment between the theory of factory-built construction and the realities of the building industry.
The author notes that over the past decade, a host of companies raised large sums and promised to transform construction, only to fold or sell their assets at fire-sale prices. Examples include Katerra, which raised around $2 billion and went bankrupt; Veev, which collapsed after a funding round failed; and Entekra, whose operations were shut down when it couldn’t expand regionally. Blu Homes, Factory_OS, and Revolution Precrafted also failed to reach a durable scale. None produced a major exit or established a sustainable category leader.
The author identifies four critical misalignments at the heart of the problem: factory economics, builder adoption and risk, fragmented construction markets, and the capital models used to fund these ventures. Factories require consistent, high utilization to be profitable, yet construction demand is seasonal, project-based, and unpredictable. Mid-size builders, the backbone of regional markets, are slow to adopt unfamiliar industrial processes, while large national builders have little incentive to change existing workflows. Regulatory and regional variations further complicate standardization. Venture capital’s expectation of rapid, outsized growth also conflicts with long-cycle industrial economics.
The paper concludes that industrialization itself hasn’t failed; the first generation pursued models that didn’t align with the economic and operational landscape of construction. A successful next phase, the author argues, will need smaller, flexible micro-factories aligned with committed demand, component-level industrialization that integrates with current builder practices, patient capital suited to long cycles, and tools, including AI, to reduce supply chain variability. In this framing, the lesson from the graveyard is not abandonment but recalibration of strategy.